Literature DB >> 32211964

Association between myocardial hypoxia and fibrosis in hypertrophic cardiomyopathy: analysis by T2* BOLD and T1 mapping MRI.

Kiyoe Ando1, Michinobu Nagao2, Eri Watanabe1, Akiko Sakai1, Atsushi Suzuki1, Risako Nakao1, Umiko Ishizaki3, Shuji Sakai3, Nobuhisa Hagiwara1.   

Abstract

OBJECTIVES: We assessed whether an association exists between myocardial oxygenation and myocardial fibrosis in patients with hypertrophic cardiomyopathy (HCM), using blood-oxygen-level-dependent (BOLD) T2* cardiac magnetic resonance imaging (T2*-CMR) and T1 mapping.
METHODS: T1 mapping and T2*-CMR data were collected from 55 HCM patients using a 3-T MR and were prospectively analyzed. T2*-CMR was conducted using the black blood, breath-hold, multi-echo, and gradient echo sequence. Over 10 min, inhalation of oxygen at the flow rate of 10 L/min, T2* for mid-septum was measured following room-air and oxygen inhalation, and ΔT2* ratio (T2*oxy-T2*air/T2*air, %) was calculated. During pre- and post-gadolinium enhancement, native T1 (ms) and extracellular volume fractions (ECV, %) were calculated at sites same as the T2* measurement. Hypoxia was defined as the segment with an absolute value of the ΔT2* ratio ≥ 10%.
RESULTS: ΔT2* ratio was significantly higher for segments with native T1 ≥ 1290 ms than those with native T1 < 1290 ms (21 ± 32% vs. 8 ± 6%, p = 0.005). ΔT2* ratio was also significantly higher for segments with ECV ≥ 28% than those with ECV < 28% (21 ± 32% vs. 8 ± 8%, p = 0.0003). ROC curve analysis revealed that ΔT2* ratio could detect segments with native T1 ≥ 1290 ms and ECV ≥ 28% and c-statistics of 0.72 and 0.79. According to the multivariate logistic regression analysis results, ECV is an independent factor in hypoxia (odds ratio, 1.47; 95% confidence interval, 1.02-2.13; p < 0.05).
CONCLUSIONS: Analysis of BOLD T2*-CMR and T1 mapping revealed that ECV is strongly associated with ΔT2* ratio, suggesting that the onset of myocardial fibrosis is related to hypoxia in HCM patients. TRIAL REGISTRATION: Our study was approved by the ethics committee of our institute (#4036, registered on 21 July 2016) KEY POINTS: • Analysis of ΔT2* ratio and ECV with BOLD-T2* and T1 mapping revealed a strong association between myocardial fibrosis and hypoxia in HCM patients.

Entities:  

Keywords:  Fibrosis; Functional magnetic resonance imaging; Hypertrophic cardiomyopathy; Hypoxia

Mesh:

Substances:

Year:  2020        PMID: 32211964     DOI: 10.1007/s00330-020-06779-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  3 in total

1.  Age and sex corrected normal reference values of T1, T2 T2* and ECV in healthy subjects at 3T CMR.

Authors:  Clotilde Roy; Alisson Slimani; Christophe de Meester; Mihaela Amzulescu; Agnès Pasquet; David Vancraeynest; Jean-Louis Vanoverschelde; Anne-Catherine Pouleur; Bernhard L Gerber
Journal:  J Cardiovasc Magn Reson       Date:  2017-09-21       Impact factor: 5.364

2.  Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.

Authors:  Peter P Swoboda; Adam K McDiarmid; Bara Erhayiem; Graham R Law; Pankaj Garg; David A Broadbent; David P Ripley; Tarique A Musa; Laura E Dobson; James R Foley; Graham J Fent; Stephen P Page; John P Greenwood; Sven Plein
Journal:  J Cardiovasc Magn Reson       Date:  2017-02-20       Impact factor: 5.364

Review 3.  Oxygenation-sensitive cardiovascular magnetic resonance.

Authors:  Matthias G Friedrich; Theodoros D Karamitsos
Journal:  J Cardiovasc Magn Reson       Date:  2013-05-24       Impact factor: 5.364

  3 in total
  4 in total

Review 1.  The Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Hypertrophic Cardiomyopathy.

Authors:  Sanjay Sivalokanathan
Journal:  Diagnostics (Basel)       Date:  2022-01-26

2.  Acupuncture at Neiguan suppresses PVCs occurring post-myocardial infarction by alleviating inflammation and fibrosis.

Authors:  Hao Hong; Xin Cao; Tian Deng; Xiang-Min Meng; Yu-Meng Li; Li-Juan Zhu; Jing Lv; Xuan Li; Shu-Guang Yu; Bing-Mei Zhu
Journal:  Chin Med       Date:  2022-04-28       Impact factor: 4.546

3.  Different Impacts on the Heart After COVID-19 Infection and Vaccination: Insights From Cardiovascular Magnetic Resonance.

Authors:  Jan Gröschel; Yashraj Bhoyroo; Edyta Blaszczyk; Ralf Felix Trauzeddel; Darian Viezzer; Hadil Saad; Maximilian Fenski; Jeanette Schulz-Menger
Journal:  Front Cardiovasc Med       Date:  2022-07-14

4.  Impact of cardiac magnetic resonance on the diagnosis of hypertrophic cardiomyopathy - a 10-year experience with over 1000 patients.

Authors:  Mateusz Śpiewak; Mariusz Kłopotowski; Natalia Ojrzyńska; Joanna Petryka-Mazurkiewicz; Barbara Miłosz-Wieczorek; Łukasz Mazurkiewicz; Jacek Grzybowski; Zofia Bilińska; Adam Witkowski; Magdalena Marczak
Journal:  Eur Radiol       Date:  2020-09-02       Impact factor: 5.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.